Compare ARK Genomic Revolution ETF (ARKG) vs KraneShares Hang Seng TECH Index ETF (KTEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs KraneShares Hang Seng TECH Index ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.91, while KraneShares Hang Seng TECH Index ETF trades at $13.04. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, KraneShares Hang Seng TECH Index ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | KTEC | |
|---|---|---|
Sector | Sector/Thematic | Sector/Thematic |
52-Week High | $43.57 | $19.51 |
52-Week Low | $23.09 | $12.00 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
KTEC trades at $13.04, down 0.38% with a bullish technical signal from moving averages. The stock shows mixed momentum with a neutral oscillator reading. Support levels cluster around $12-$13 while resistance sits at $13-$14. Key financial ratios including P/E, P/S, and profitability metrics remain unavailable in current data.
The technical setup suggests potential upside if the stock holds above $13 support, though the elevated 6-day RSI indicates near-term overbought conditions. Investment appeal depends on forthcoming financial disclosures to assess valuation and growth prospects against sector peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About KraneShares Hang Seng TECH Index ETF
KTEC tracks the Hang Seng TECH Index, providing targeted exposure to the 30 largest technology companies listed on the Hong Kong Stock Exchange. It focuses on innovative, internet-based businesses across sectors like e-commerce, fintech, cloud computing, and digital technology.
Read more on KTEC →
